COCCIOLONE, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 464
EU - Europa 391
AS - Asia 150
SA - Sud America 4
OC - Oceania 3
Totale 1.012
Nazione #
US - Stati Uniti d'America 461
IE - Irlanda 97
IT - Italia 95
CN - Cina 83
SE - Svezia 57
DE - Germania 46
TR - Turchia 39
UA - Ucraina 26
GB - Regno Unito 19
CZ - Repubblica Ceca 13
FI - Finlandia 13
VN - Vietnam 10
RU - Federazione Russa 7
SG - Singapore 7
FR - Francia 6
IN - India 6
TH - Thailandia 4
AU - Australia 3
CA - Canada 3
BE - Belgio 2
PT - Portogallo 2
RO - Romania 2
BG - Bulgaria 1
BR - Brasile 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
GR - Grecia 1
ID - Indonesia 1
MC - Monaco 1
PE - Perù 1
PL - Polonia 1
RS - Serbia 1
Totale 1.012
Città #
Chandler 108
Dublin 97
Jacksonville 96
Wilmington 29
Izmir 22
Nanjing 22
Boardman 19
L'aquila 17
Ashburn 16
New York 14
Bremen 13
Brno 13
Lawrence 13
Princeton 13
Beijing 11
Monza 9
Dong Ket 8
Houston 8
Milan 8
Redwood City 8
Shenyang 8
Ann Arbor 7
Rome 7
San Mateo 7
Singapore 7
Berlin 6
Falls Church 6
Dallas 5
Hebei 5
Helsinki 5
Jinan 5
Woodbridge 5
Aquila 4
Munich 4
Pescara 4
Dearborn 3
Kunming 3
London 3
Mountain View 3
Nanchang 3
Songkhla 3
Sydney 3
Tianjin 3
Brussels 2
Bucharest 2
Columbia 2
Guangzhou 2
Hanoi 2
Moscow 2
Pune 2
Seattle 2
Taizhou 2
Verona 2
Antalya 1
Arielli 1
Arzignano 1
Athens 1
Bangkok 1
Belluno 1
Fremont 1
Grafing 1
Haikou 1
Hefei 1
Istanbul 1
Jiaxing 1
Katowice 1
Kazan 1
Lappeenranta 1
Lima 1
Los Angeles 1
Monaco 1
Norwalk 1
Onalaska 1
Palermo 1
Poli 1
Qingdao 1
Red Deer 1
Saint Petersburg 1
San Francisco 1
Shanghai 1
Stockholm 1
Tallinn 1
Tappahannock 1
Toronto 1
Washington 1
Yekaterinburg 1
Zhengzhou 1
Épinay-sous-sénart 1
Totale 708
Nome #
Breast cancer and psychological resilience among young women 196
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 98
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 96
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 95
Bone targeted therapy for preventing skeletal-related events in metastatic breast cancer 85
Dose-dense nonpegylated liposomal doxorubicin and docetaxel combination in breast cancer: Dose-finding study 81
New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting 81
Oncology together for L'Aquila: early resumption of integrated oncological activities after the earthquake 76
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 65
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice 47
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 47
First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience 44
Looking for a place for dose-dense TMZ regimens in GBM patients: An experience with MGMT exploratory evaluation 40
Totale 1.051
Categoria #
all - tutte 3.721
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.721


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020113 0 3 16 5 2 12 32 8 18 2 2 13
2020/2021160 1 14 1 15 17 7 16 12 20 8 23 26
2021/202297 6 1 27 8 6 4 3 7 6 0 5 24
2022/2023293 13 28 2 46 33 25 0 16 120 1 5 4
2023/2024103 6 3 1 4 10 29 0 4 0 10 11 25
2024/202524 11 13 0 0 0 0 0 0 0 0 0 0
Totale 1.051